Literature DB >> 16382337

Molecular mechanisms of the alterations in NMDA receptor-dependent long-term potentiation in hyperammonemia.

Pilar Monfort1, María-Dolores Muñoz, Vicente Felipo.   

Abstract

Long-term potentiation (LTP) is a long-lasting enhancement of synaptic transmission efficacy and is considered the base for some forms of learning and memory. Hyperammonemia impairs LTP in hippocampus. Proper LTP induction in hippocampal slices requires activation of the soluble guanylate cyclase (sGC)-protein kinase G (PKG)-cyclic guanosine monophosphate (cGMP)-degrading phosphodiesterase pathway. Hyperammonemia impairs LTP by impairing the tetanus-induced activation of this pathway. The tetanus induces a rapid cGMP rise, reaching a maximum at 10 s, both in the absence or in the presence of ammonia. The increase in cGMP is followed, in control slices, by a sustained decrease in cGMP because of PKG-mediated activation of cGMP-degrading phosphodiesterase, which is required for maintenance of LTP. Hyperammonemia prevents completely tetanus-induced decrease in cGMP by impairing PKG-mediated activation of cGMP-degrading phosphodiesterase. Addition of 8 Br-cGMP to slices treated with ammonia restores both phosphodiesterase activation and maintenance of LTP. Impairment of LTP in hyperammonemia may be involved in the impairment of the cognitive function in patients with hepatic encephalopathy.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16382337     DOI: 10.1007/s11011-005-7905-5

Source DB:  PubMed          Journal:  Metab Brain Dis        ISSN: 0885-7490            Impact factor:   3.584


  32 in total

1.  Nitric oxide signaling contributes to late-phase LTP and CREB phosphorylation in the hippocampus.

Authors:  Y F Lu; E R Kandel; R D Hawkins
Journal:  J Neurosci       Date:  1999-12-01       Impact factor: 6.167

2.  Examination of the role of cGMP in long-term potentiation in the CA1 region of the hippocampus.

Authors:  D K Selig; M R Segal; D Liao; R C Malenka; R Malinow; R A Nicoll; J E Lisman
Journal:  Learn Mem       Date:  1996 Jul-Aug       Impact factor: 2.460

3.  Protein kinase C inhibitors eliminate hippocampal long-term potentiation.

Authors:  D M Lovinger; K L Wong; K Murakami; A Routtenberg
Journal:  Brain Res       Date:  1987-12-08       Impact factor: 3.252

4.  Hyperammonemia impairs NMDA receptor-dependent long-term potentiation in the CA1 of rat hippocampus in vitro.

Authors:  M D Muñoz; P Monfort; J M Gaztelu; V Felipo
Journal:  Neurochem Res       Date:  2000-04       Impact factor: 3.996

Review 5.  NO honey, I don't remember.

Authors:  R D Hawkins
Journal:  Neuron       Date:  1996-03       Impact factor: 17.173

Review 6.  Glutamate and muscarinic receptors in the molecular mechanisms of acute ammonia toxicity and of its prevention.

Authors:  M D Miñana; M Llansola; C Hermenegildo; C Cucarella; C Montoliu; E Kosenko; S Grisolía; V Felipo
Journal:  Adv Exp Med Biol       Date:  1997       Impact factor: 2.622

7.  Translocation of protein kinase C activity may mediate hippocampal long-term potentiation.

Authors:  R F Akers; D M Lovinger; P A Colley; D J Linden; A Routtenberg
Journal:  Science       Date:  1986-02-07       Impact factor: 47.728

8.  Tests of the roles of two diffusible substances in long-term potentiation: evidence for nitric oxide as a possible early retrograde messenger.

Authors:  T J O'Dell; R D Hawkins; E R Kandel; O Arancio
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

Review 9.  Neurobiology of ammonia.

Authors:  Vicente Felipo; Roger F Butterworth
Journal:  Prog Neurobiol       Date:  2002-07       Impact factor: 11.685

10.  Nitric oxide-dependent long-term potentiation is blocked by a specific inhibitor of soluble guanylyl cyclase.

Authors:  C L Boulton; E Southam; J Garthwaite
Journal:  Neuroscience       Date:  1995-12       Impact factor: 3.590

View more
  11 in total

1.  Dynamics of learning in cultured neuronal networks with antagonists of glutamate receptors.

Authors:  Yanling Li; Wei Zhou; Xiangning Li; Shaoqun Zeng; Qingming Luo
Journal:  Biophys J       Date:  2007-08-31       Impact factor: 4.033

2.  Structural basis for the catalytic mechanism of human phosphodiesterase 9.

Authors:  Shenping Liu; Mahmoud N Mansour; Keith S Dillman; Jose R Perez; Dennis E Danley; Paul A Aeed; Samuel P Simons; Peter K Lemotte; Frank S Menniti
Journal:  Proc Natl Acad Sci U S A       Date:  2008-08-29       Impact factor: 11.205

3.  Urea cycle defects and hyperammonemia: effects on functional imaging.

Authors:  Andrea L Gropman; Morgan Prust; Andrew Breeden; Stanley Fricke; John VanMeter
Journal:  Metab Brain Dis       Date:  2012-11-13       Impact factor: 3.584

4.  Hepatic encephalopathy: An approach to its multiple pathophysiological features.

Authors:  Juan Carlos Perazzo; Silvina Tallis; Amalia Delfante; Pablo Andrés Souto; Abraham Lemberg; Francisco Xavier Eizayaga; Salvador Romay
Journal:  World J Hepatol       Date:  2012-03-27

5.  Hepatic encephalopathy: a review of its pathophysiology and treatment.

Authors:  Nader Dbouk; Brendan M McGuire
Journal:  Curr Treat Options Gastroenterol       Date:  2006

6.  Hyperammonemia Alters the Function of AMPA and NMDA Receptors in Hippocampus: Extracellular cGMP Reverses Some of These Alterations.

Authors:  María Sancho-Alonso; Lucas Taoro-Gonzalez; Andrea Cabrera-Pastor; Vicente Felipo; Vicent Teruel-Martí
Journal:  Neurochem Res       Date:  2022-04-06       Impact factor: 3.996

Review 7.  Neurological implications of urea cycle disorders.

Authors:  A L Gropman; M Summar; J V Leonard
Journal:  J Inherit Metab Dis       Date:  2007-11-23       Impact factor: 4.982

8.  Brain creatine kinase activity is inhibited after hepatic failure induced by carbon tetrachloride or acetaminophen.

Authors:  Gustavo S Pacheco; Jordana P Panatto; Diego A Fagundes; Giselli Scaini; Cintia Bassani; Isabela C Jeremias; Gislaine T Rezin; Larissa Constantino; Felipe Dal-Pizzol; Emilio L Streck
Journal:  Metab Brain Dis       Date:  2009-08-18       Impact factor: 3.584

Review 9.  Hyperammonemia in Hepatic Encephalopathy.

Authors:  A R Jayakumar; Michael D Norenberg
Journal:  J Clin Exp Hepatol       Date:  2018-06-20

10.  The CNS-Penetrant Soluble Guanylate Cyclase Stimulator CY6463 Reveals its Therapeutic Potential in Neurodegenerative Diseases.

Authors:  Susana S Correia; Rajesh R Iyengar; Peter Germano; Kim Tang; Sylvie G Bernier; Chad D Schwartzkopf; Jenny Tobin; Thomas W-H Lee; Guang Liu; Sarah Jacobson; Andrew Carvalho; Glen R Rennie; Joon Jung; Paul A Renhowe; Elisabeth Lonie; Christopher J Winrow; John R Hadcock; Juli E Jones; Mark G Currie
Journal:  Front Pharmacol       Date:  2021-05-24       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.